11/7/2008

John McLaughlin will take over as president and CEO of PDL BioPharma after the company spins off its biotech assets. McLaughlin, who held positions at Genentech and Anesiva, began serving on PDL's board of directors in October.

Full Story:
Forbes

Related Summaries